Although serum biomarkers (LPS and zonulin) correlate with NAFLD severity (Guan et al., 2022; Teunis et al., 2022; Wang et al., 2020), most of the evidence is observational, with limited mechanistic studies focusing on GLA pathways. Here, HP is linked to metabolic dysfunction-associated steatotic liver disease.